Trade Analytics
Pharmaceuticals
India's pharmaceutical sector will touch US$ 45 billion by 2020.

Indian Pharmaceuticals Industry Analysis

Latest update: November, 2016

Increasing investments in the sector

  • The Indian pharmaceuticals market increased at a CAGR of 17.46 per cent during 2005-16 with the market increasing from US$ 6 billion in 2005 to US$ 36.7 billion in 2016 and is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020.
  • By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size.
  • India’s cost of production is significantly lower than that of the US and almost half of that of Europe. It gives a competitive edge to India over others.
Growth

Generic drugs form the largest segment

  • With 70 per cent of market share (in terms of revenues), generic drugs form the largest segment of the Indian pharmaceutical sector.
  • India supply 20 per cent of global generic medicines market exports in terms of volume, making the country the largest provider of generic medicines globally and expected to expand even further in coming years
  • Over the Counter (OTC) medicines and patented drugsconstitute 21 per cent and 9 per cent, respectively, of total market revenues of US$ 20 billion
Growth

 

Last Updated: November, 2016

Indian pharmaceutical sector accounts for about 2.4 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms and is expected to expand at a Compound Annual Growth Rate (CAGR) of 15.92 per cent to US$ 55 billion by 2020 from US$ 20 billion in 2015. 

With 71 per cent market share, generic drugs form the largest segment of the Indian pharmaceutical sector. By 2016, India is expected to be the third-largest global generic Active Pharmaceutical Ingredient (API) merchant market. The country accounts for the second largest number of Abbreviated New Drug Applications (ANDAs) and is the world’s leader in Drug Master Files (DMFs) applications with the US.

Indian drugs are exported to more than 200 countries in the world, with the US as the key market. Generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally and expected to expand even further in coming years. Pharmaceuticals Exports Promotion Council (Pharmexcil) expects pharmaceutical exports to reach US$ 25 billion in 2015.

The Government of India plans to set up a US$ 640 million venture capital fund to boost drug discovery and strengthen pharmaceutical infrastructure. The ‘Pharma Vision 2020’ by the government’s Department of Pharmaceuticals aims to make India a major hub for end-to-end drug discovery.

Sectoral Presentation (November, 2016)

Download PDF   Download  (Size: 790.04 KB )

Posters

Brand India Pharma

WINNING THE WORLD

Indian pharma company have won around 40 per cent of all Abbreviated New Drug Approval (ANDA) from the US Food and Drug Administration (FDA) between j...

+ More >

Brand India Pharma

IBEF Publications

IBEF Publication

India Now Magazine


India Now Business and Economy

English

+ More Publications >

IBEF Publication

Blog – Perspectives on India More

Powered by the Who's Who of India

author_Almirah1.jpg Reinventing traditional Indian fashion with a modern twist
Aditi Bajpai, Co-Founder & Designer, Almirah

How connecting with Indian crafts and silhouettes is making room for new business models

Almirah, a conscious clothing and bedding label for chi...

author_Anu_P._Mathai_photo_1_-_mobile_photo_1.jpg India’s economy: On a strong foundation
Anu P. Mathai, IES, Chief Executive Officer, IBEF

India's core sector output index grew by 5 per cent year-on-year at 176.1 in September 2016, as compared with 3.2 per cent year-on-year growth recorded in August 2016...

author_unnamed2.jpg Kent RO Systems: All about purity!
Dr. Mahesh Gupta, Chairman & Managing Director, Kent RO Systems Ltd

Kent RO Systems is known for revolutionising the water purification industry in India. The company today commands a market share of about 40 per cent in RO water purifier...

author_Anu_P._Mathai_photo_1_-_mobile_photo_1.jpg Mobile The best way to reach the consumer?
Anu P. Mathai, IES, Chief Executive Officer, IBEF

The mobile phone has become one of the primary devices used by the consumer today across the globe. A similar trend is visible in the Indian market as well. With a total ...

author_Anu_P._Mathai_photo_1_-_mobile_photo_1.jpg Indian film industry to reach US$ 3.7 billion by 2020
Anu P. Mathai, IES, Chief Executive Officer, IBEF

The Indian film industry is expected to grow at a compounded annual growth rate (CAGR) of 11 per cent to reach US$ 3.7 billion by 2020, according to a recently released r...

author_Narayan_51.jpg Decoding GST for manufacturing SMEs
Mr. R. Narayan, Founder & CEO, Power2SME

As the eagerly and anxiously awaited Goods and Services Tax (GST) Bill, 2016 sailed through the Rajya Sabha with two-thirds majority in which 203 members voted i...

ideas More

Ideas

3Nethra - Providing Vision of Hope
K Chandrasekhar founder of Forus Health has created 3Nethra, a compact portable optical diagnostic machine that can be used by ophthalmologists in any place or conditions. The inspiration behind the creation of 3Nethra was to treat preventable blindness, which comprise of 80 per cent of blind population of India, which itself...

JOIN IBEF.org

Join IBEF.org now. Enjoy FREE subscriptions downloads, updates and more.

Error

Already a member?
Login / Retrieve Password